Hashimoto's thyroiditis shares features with early papillary thyroid carcinoma
- 15 October 2002
- journal article
- review article
- Published by Wiley in Histopathology
- Vol. 41 (4), 357-362
- https://doi.org/10.1046/j.1365-2559.2002.01467.x
Abstract
Neoplastic transformation is a multistep process that results in a continuous spectrum from the normal (physiological) state to a fully established neoplasm. The gold standard for diagnosis of papillary thyroid carcinoma is conventional histology, the essential element being the characteristic nuclear features, regardless of whether papillary structures are present or not. However, other criteria are being used increasingly in the diagnosis of neoplasms, including immunohistochemical staining and molecular profile. The RET/PTC gene rearrangement is highly specific for papillary thyroid carcinoma and is associated with the characteristic nuclear features seen in papillary thyroid carcinoma. There is an overlap in the morphological features, immunohistochemical staining pattern, and most importantly, molecular profile between papillary thyroid carcinoma and Hashimoto's thyroiditis. Although considered a ‘benign’ condition, Hashimoto's thyroiditis almost always harbours a genetic rearrangement that is strongly associated with and is highly specific for papillary thyroid carcinoma. Submicroscopic foci of papillary thyroid carcinoma must be present in Hashimoto's thyroiditis, although the clinical behaviour is still benign. Further studies are required to predict which foci will progress to papillary thyroid carcinoma.Keywords
This publication has 23 references indexed in Scilit:
- Immunohistochemical Diagnosis of Papillary Thyroid CarcinomaLaboratory Investigation, 2001
- Papillary Thyroid Carcinoma Associated with Papillary Renal Neoplasia: Genetic Linkage Analysis of a Distinct Heritable Tumor SyndromeJournal of Clinical Endocrinology & Metabolism, 2000
- The ret/PTC Mutations Are Common in Sporadic Papillary Thyroid Carcinoma of Children and Young AdultsJournal of Clinical Endocrinology & Metabolism, 2000
- Molecular Basis of Hurthle Cell Papillary Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 2000
- Genetic Heterogeneity in Familial Nonmedullary Thyroid Carcinoma: Exclusion of Linkage to RET, MNG1, and TCO in 56 FamiliesJournal of Clinical Endocrinology & Metabolism, 1999
- Papillary Thyroid Carcinoma Oncogene (RET/PTC) Alters the Nuclear Envelope and Chromatin StructureThe American Journal of Pathology, 1998
- Distinct Multiple RET/PTC Gene Rearrangements in Multifocal Papillary Thyroid NeoplasiaJournal of Clinical Endocrinology & Metabolism, 1998
- High prevalence of activating ret proto-oncogene rearrangements, in thyroid tumors from patients who had received external radiationOncogene, 1997
- Expression of the RET/PTC Fusion Gene as a Marker for Papillary Carcinoma in Hashimoto's ThyroiditisThe Laryngoscope, 1997
- Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.JCI Insight, 1992